Immunogen OverviewImmunogen EBIT
EBIT (Earnings Before Interest and Taxes) analysis for IMGN.
Quarterly EBIT
$25.96M
↑ 133.52% YoY
As of Sep 30, 2023
Annual EBIT (TTM)
-$78.72M
↑ 59.82% YoY
Trailing 12 months ending Sep 30, 2023
Immunogen OverviewEBIT (Earnings Before Interest and Taxes) analysis for IMGN.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023